1. Home
  2. HERE vs OABI Comparison

HERE vs OABI Comparison

Compare HERE & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HERE

Here Group Limited American Depositary Shares

N/A

Current Price

$3.37

Market Cap

192.5M

Sector

Real Estate

ML Signal

N/A

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$1.46

Market Cap

225.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HERE
OABI
Founded
2019
2012
Country
China
United States
Employees
714
89
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
192.5M
225.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HERE
OABI
Price
$3.37
$1.46
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
201.5K
288.0K
Earning Date
03-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$52.42
Revenue Next Year
$79.29
$64.69
P/E Ratio
$2.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.89
$1.22
52 Week High
$5.80
$2.22

Technical Indicators

Market Signals
Indicator
HERE
OABI
Relative Strength Index (RSI) 45.61 29.70
Support Level $2.89 $1.32
Resistance Level $4.71 $1.72
Average True Range (ATR) 0.26 0.07
MACD 0.04 -0.01
Stochastic Oscillator 56.98 10.17

Price Performance

Historical Comparison
HERE
OABI

About HERE Here Group Limited American Depositary Shares

Here Group Ltd is dedicated to creating collectible pop toys that evoke joy and emotional resonance. The group design and compelling storytelling, which provide users with a collecting experience that blends artistic value with emotional warmth, continuously convey a joyful and immersive brand culture. Adhering to the brand philosophy of joy, integrity, wonder, and co-creation, the company is building a vibrant ecosystem connecting creativity and emotion, working hand-in-hand with overall toy enthusiasts to create, share, and transmit dreams.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: